StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$25.13+0.92 (+3.80%)

Close on Nov 18, 2026Market cap $691.46MP/E –Yield –

Fulgent Genetics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Fulgent Genetics's operating income for the twelve months ending Jun 30, 2026 was -$122.28M. For fiscal 2025 it was -$91.10M. The highest annual figure on record is $675.95M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$91.10M–
FY2024Dec 31, 2024-$73.92M–
FY2023Dec 31, 2023-$195.53M-209.5%
FY2022Dec 31, 2022$178.53M-73.6%
FY2021Dec 31, 2021$675.95M+133.0%
FY2020Dec 31, 2020$290.16M–
FY2019Dec 31, 2019-$428.00K–
FY2018Dec 31, 2018-$5.07M–
FY2017Dec 31, 2017-$3.48M-479.3%
FY2016Dec 31, 2016$918.00K–
FY2015Dec 31, 2015-$5.01M–
FY2014Dec 31, 2014-$990.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$36.07M–
Q1 FY2026Mar 31, 2026-$34.62M–
Q4 FY2025Dec 31, 2025-$36.24M–
Q3 FY2025Sep 30, 2025-$15.35M–
Q2 FY2025Jun 30, 2025-$19.71M–
Q1 FY2025Mar 31, 2025-$19.80M–
Q4 FY2024Dec 31, 2024-$16.14M–
Q3 FY2024Sep 30, 2024-$17.08M-8080.8%
Q2 FY2024Jun 30, 2024-$18.91M–
Q1 FY2024Mar 31, 2024-$21.80M–
Q4 FY2023Dec 31, 2023-$151.12M–
Q3 FY2023Sep 30, 2023$214.00K-39.2%
Q2 FY2023Jun 30, 2023-$19.80M-254.7%
Q1 FY2023Mar 31, 2023-$24.82M-112.3%
Q4 FY2022Dec 31, 2022-$36.55M-124.2%
Q3 FY2022Sep 30, 2022$352.00K-99.8%
Q2 FY2022Jun 30, 2022$12.79M-87.1%
Q1 FY2022Mar 31, 2022$201.93M-24.3%
Q4 FY2021Dec 31, 2021$150.86M-33.2%
Q3 FY2021Sep 30, 2021$159.27M+150.7%
Q2 FY2021Jun 30, 2021$98.90M+3646.1%
Q1 FY2021Mar 31, 2021$266.92M–
Q4 FY2020Dec 31, 2020$225.91M–
Q3 FY2020Sep 30, 2020$63.52M+4109.6%
Q2 FY2020Jun 30, 2020$2.64M+794.9%
Q1 FY2020Mar 31, 2020-$1.91M–
Q4 FY2019Dec 31, 2019-$409.00K–
Q3 FY2019Sep 30, 2019$1.51M–
Q2 FY2019Jun 30, 2019$295.00K–
Q1 FY2019Mar 31, 2019-$1.82M–
Q4 FY2018Dec 31, 2018-$1.03M–
Q3 FY2018Sep 30, 2018-$846.00K–
Q2 FY2018Jun 30, 2018-$1.00M–
Q1 FY2018Mar 31, 2018-$2.19M-1101.8%
Q4 FY2017Dec 31, 2017-$2.07M-264.4%
Q3 FY2017Sep 30, 2017-$1.48M–
Q2 FY2017Jun 30, 2017-$150.00K–
Q1 FY2017Mar 31, 2017$219.00K–
Q4 FY2016Dec 31, 2016$1.26M–
Q3 FY2016Sep 30, 2016-$695.00K–

More Fulgent Genetics figures

See a number that looks wrong?